Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Different Applications of Virus-Like Particles in Biology and Medicine: Vaccination and Delivery Systems Publisher Pubmed



Shirbaghaee Z1, 2 ; Bolhassani A1
Authors

Source: Biopolymers Published:2016


Abstract

Virus-like particles (VLPs) mimic the whole construct of virus particles devoid of viral genome as used in subunit vaccine design. VLPs can elicit efficient protective immunity as direct immunogens compared to soluble antigens co-administered with adjuvants in several booster injections. Up to now, several prokaryotic and eukaryotic systems such as insect, yeast, plant, and E. coli were used to express recombinant proteins, especially for VLP production. Recent studies are also generating VLPs in plants using different transient expression vectors for edible vaccines. VLPs and viral particles have been applied for different functions such as gene therapy, vaccination, nanotechnology, and diagnostics. Herein, we describe VLP production in different systems as well as its applications in biology and medicine. © 2015 Wiley Periodicals, Inc. Biopolymers 105: 113–132, 2016. © 2015 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. A Live Vector Expressing Hpv16 L1 Generates an Adjuvant-Induced Antibody Response In-Vivo, International Journal of Cancer Management (2015)
2. Plant-Based Vaccines and Cancer Therapy: Where Are We Now and Where Are We Going?, Pharmacological Research (2021)
3. Formation of Self-Assembled Triple-Layered Rotavirus-Like Particles (Tlrlps) by Constitutive Co-Expression of Vp2, Vp6, and Vp7 in Stably Transfected High-Five Insect Cell Lines, Journal of Medical Virology (2015)
Experts (# of related papers)
View all Related Experts
Somayeh Jalilvand (3)
Nima Rezaei (2)
Other Related Docs
4. Co-Utilization of a Tlr5 Agonist and Nano-Formulation of Hiv-1 Vaccine Candidate Leads to Increased Vaccine Immunogenicity and Decreased Immunogenic Dose: A Preliminary Study, Immunology Letters (2017)
5. Cracking the Human Cytomegalovirus Code: Trinary Challenges of Latency, Immune Evasion, and Correlates of Protection, Iranian Journal of Allergy, Asthma and Immunology (2025)
6. D D a Strategies to Designing Chimeric Recombinant Vaccines, Journal of Applied Biotechnology Reports (2021)
7. Influenza Vaccine: Where Are We and Where Do We Go?, Reviews in Medical Virology (2019)
8. Review on Approved and Inprogress Covid-19 Vaccines, Iranian Journal of Pharmaceutical Research (2022)
9. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
10. Novel Approach to Improve Vaccine Immunogenicity: Mannosylated Chitosan Nanoparticles Loaded With Recombinant Hepatitis B Antigen As a Targeted Vaccine Delivery System, Journal of Drug Delivery Science and Technology (2018)
11. Co-Administration of Rotavirus Nanospheres Vp6 and Nsp4 Proteins Enhanced the Anti-Nsp4 Humoral Responses in Immunized Mice, Microbial Pathogenesis (2022)
12. Recombinant Hemagglutinin of Swine H1n1 Influenza Virus Expression in the Insect Cells: Formulation in Montanide Isa71 Adjuvant and the Potency Studies, Iranian Journal of Basic Medical Sciences (2021)
13. Genetic Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
14. Simultaneous Formulation of Influenza Vaccine and Chitosan Nanoparticles Within Cpg Oligodesoxi Nucleotides Leads to Dose-Sparing and Protects Against Lethal Challenge in the Mouse Model, Pathogens and Disease (2018)
15. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
16. Rotavirus Vp6: Involvement in Immunogenicity, Adjuvant Activity, and Use As a Vector for Heterologous Peptides, Drug Delivery, and Production of Nano-Biomaterials, Archives of Virology (2022)
17. Development and Characteristics of Novel Plga-Chitosan As a New Nano-Carrier for Pentavalent Vaccine Delivery, Current Pharmaceutical Biotechnology (2021)
18. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
19. Heterologous Administration of Hpv16 E7 Epitope-Loaded Nanocomplexes Inhibits Tumor Growth in Mouse Model, International Immunopharmacology (2021)
20. Expression of Phlebotomus Papatasi Salivary Protein 15 (Ppsp15) in Cos-7 Cells, Journal of Arthropod-Borne Diseases (2024)